Message from the President​

Professor Clive Page, President of the BPS 2022-2023

Serving my first year as President of the Society in 2022 was a privilege. Collaborating with members and working with staff on several key projects was hugely rewarding.

One of the most exciting parts of 2022 for me was being able to return to in-person meetings. We delivered a face-to-face annual meeting in Liverpool in September 2022, which allowed our community to do what we do best – get together, share our science, and have a great time networking and meeting new and old friends.

A particular highlight for me was one of our focus meetings, ‘Lungs: More than an organ of gas exchange’. This meeting, delivered in partnership with The Physiological Society, brought together people working in respiratory health, combining pharmacology and physiology in an excited blended meeting.

Dr Andrew Shrimpton, NIHR Doctoral Fellow at University of Bristol, giving a lecture titled 'Aerosol quantitation during Cardiopulmonary Resuscitation: Is CPR a high-risk aerosol generating procedure?' at the British Pharmacological Society and The Physiological Society's joint-meeting, 'Lungs: More than an organ of gas exchange'.

Partnerships have continued to be important to us at the Society, and in 2022 we developed and strengthened these. We continue our Guest Society partnership with the American Society for Pharmacology and Experimental Therapeutics (ASPET), which means that we will each host a lecture, symposium or sponsorship at our respective annual meetings until at least 2028. In addition, we continued to work closely with ELRIG, and held the session ‘Drug Discovery and Development in Chronic Obstructive Pulmonary Disease (COPD)’ at ELRIG’s ‘Drug Discovery 2022’ meeting in London.

Professor Dave Singh, Professor of Clinical Pharmacology and Respiratory Medicine at the University of Manchester, giving a lecture at the British Pharmacological Society's 'Drug Discovery and Development in Chronic Obstructive Pulmonary Disease (COPD)' session at ELRIG's 'Drug Discovery 2022' meeting in London in October 2022.

In addition, it continued to be important to us that our members have a powerful voice in our community. Our prizes and awards showcased some of those in our membership who are doing exceptional work to advance the field, and we also announced a call for our members to propose new names for awards, ensuring our names are representative of those our community are inspired by.

These are just a small handful of the projects and experiences that made 2022 special, and I am sure that we will continue to work together as a Society to advance the practice of pharmacology for the remainder of 2023.

I would like to thank the entire pharmacology community for being involved in this busy, fruitful year – particularly our members, and the staff team. The strength of our Society has always been a result of the input of our fantastic members working in collaboration with our professional staff team, and as we continue to navigate through the effects of the COVID-19 pandemic, we are more thankful than ever for everyone's support and contributions.


Next: Strengthening the foundation of clinical pharmacology
Previous: Message from the CEO​
Go back to Annual Review 2022